COH · ASX

Cochlear Limited (ASX:COH)

AU$301.01

 -1.23 (-0.407%)
ASX:Live
26/08/2025 04:10:22 PM
HALO Ords HALO Dividend Growth HALO Capital Efficiency HALO 50 HALO 200 +7
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

COH Overview

COH Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Weak

About COH

Website

Cochlear Limited

Telephone

61.2.9428.6555

Address

Macquarie University 1 University Avenue Sydney, New South Wales (NSW) 2109

Description

Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Cochlear Implants, Services, and Acoustics. The Cochlear Implants segment deals with the treatment pathway for acquired or progressive hearing loss. The Services segment offers sound processor upgrades, accessories, and others. The Acoustic segment is for the bone conduction systems. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

COH Price Chart

Key Stats

Market Cap

AU$19.77B

PE

50.50

EV/EBITDA

32.0

Dividends Overview

DIV Yield

1.4%

Franking

85%

Ex Dividend Date (est.)

18-Sep-25

Market Data

52 weeks range

Low 246.14 - 323.0

Trade Value (12mth)

AU$12,362,722.00

1 week

0.19%

1 month

-3.39%

YTD

2.94%

1 year

0.48%

All time high

350.31

Key Fundamentals

EPS 3 yr Growth

35.20%

EBITDA Margin

25.50%

Operating Cashflow

$238m

Free Cash Flow Return

11.40%

ROIC

18.60%

Interest Coverage

54.50

Quick Ratio

1.50

Other Data

Shares on Issue (Fully Dilluted)

66m

HALO Sector

Healthcare

Next Company Report Date

13-Aug-26

Ex Dividend Date (est.)

18-Sep-25

Next Dividend Pay Date (est.)

13-Oct-25

Reporting Currency

AUD

Short Sell (% of issue)

0.88

COH Announcements

Latest Announcements

Date Announcements

25 August 25

Appendix 3X - Richard Freudenstein

×

Appendix 3X - Richard Freudenstein

25 August 25

Notification regarding unquoted securities - COH

×

Notification regarding unquoted securities - COH

25 August 25

Notification of cessation of securities - COH

×

Notification of cessation of securities - COH

25 August 25

Appendix 3Y - Diggory Howitt

×

Appendix 3Y - Diggory Howitt

15 August 25

Appendix 4E

×

Appendix 4E

15 August 25

Annual Report (incl Sustainability reporting)

×

Annual Report (incl Sustainability reporting)

15 August 25

Dividend/Distribution - COH

×

Dividend/Distribution - COH

15 August 25

FY25 Result - ASX & Media Release

×

FY25 Result - ASX & Media Release

15 August 25

FY25 Result - Presentation

×

FY25 Result - Presentation

15 August 25

2025 Tax Contribution Report

×

2025 Tax Contribution Report

15 August 25

Appendix 4G

×

Appendix 4G

15 August 25

Update - Notification of buy-back - COH

×

Update - Notification of buy-back - COH

15 August 25

Application for quotation of securities - COH

×

Application for quotation of securities - COH

15 August 25

Application for quotation of securities - COH

×

Application for quotation of securities - COH

12 August 25

Date of AGM and closing date for director nominations

×

Date of AGM and closing date for director nominations

12 August 25

Change in substantial holding

×

Change in substantial holding

29 July 25

Application for quotation of securities - COH

×

Application for quotation of securities - COH

29 July 25

Becoming a substantial holder

×

Becoming a substantial holder

28 July 25

Appointment and retirement of Non-executive Director

×

Appointment and retirement of Non-executive Director

28 July 25

Notice of FY25 result analyst and media briefing

×

Notice of FY25 result analyst and media briefing

11 July 25

Notification regarding unquoted securities - COH

×

Notification regarding unquoted securities - COH

11 July 25

Notification of cessation of securities - COH

×

Notification of cessation of securities - COH

08 July 25

Cochlear receives FDA approval for new Nucleus Nexa system

×

Cochlear receives FDA approval for new Nucleus Nexa system

12 June 25

Cochlear provides update to FY25 earnings guidance

×

Cochlear provides update to FY25 earnings guidance

12 June 25

Cochlear launches new cochlear implant system

×

Cochlear launches new cochlear implant system

COH Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 4.57 5.44 5.94 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 4.56 5.43 5.93 Lock Lock Lock
     Growth % Lock Lock Lock Lock 4.0 19.1 9.2 Lock Lock Lock
     PE X Lock Lock Lock Lock 50.0 55.9 50.5 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 31.0 35.3 32.0 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 5.94 7.09 7.73 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 1.75 1.23 -1.57 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2.2 19.4 9.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.8 0.4 -0.5 Lock Lock Lock
DPS $ Lock Lock Lock Lock 3.30 4.10 4.30 Lock Lock Lock
     Growth % Lock Lock Lock Lock 10.0 24.2 4.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.4 1.2 1.4 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 72 75 72 Lock Lock Lock
BPS $ Lock Lock Lock Lock 26.63 28.17 29.87 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 19.87 21.27 22.20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1.0 7.1 4.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 66 66 66 Lock Lock Lock
Basic m Lock Lock Lock Lock 66 66 65 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Income Statement
Sales $m Lock Lock Lock Lock 1,956 2,258 2,356 Lock Lock Lock
     Growth % Lock Lock Lock Lock 19.2 15.5 4.3 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 1,055 1,175 1,231 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 1,468 1,696 1,741 Lock Lock Lock
     Growth % Lock Lock Lock Lock 19.3 15.6 2.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 75.0 75.1 73.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 25 25 26 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 493 606 600 Lock Lock Lock
     Growth % Lock Lock Lock Lock 13.5 22.9 -1.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 25.2 26.9 25.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 81 85 90 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 412 522 509 Lock Lock Lock
     Growth % Lock Lock Lock Lock 14.0 26.5 -2.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 21.1 23.1 21.6 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 397 485 519 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 96 128 130 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 301 357 389 Lock Lock Lock
     Growth % Lock Lock Lock Lock 4.0 18.7 9.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 15.4 15.8 16.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 362 389 238 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 96 90 103 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -126 -106 -115 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -310 -324 -367 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 312 326 175 Lock Lock Lock
     Growth % Lock Lock Lock Lock -5.9 4.5 -46.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 556 514 276 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 2,569 2,745 2,825 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 163 202 194 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -354 -270 -40 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 820 905 875 Lock Lock Lock
Equity $m Lock Lock Lock Lock 1,749 1,840 1,950 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 1,911 2,043 2,144 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.7 6.9 5.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 11.7 13.0 13.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 17.2 19.4 19.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 21.2 25.9 23.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 15.9 18.0 18.6 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 19.2 19.7 11.4 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Leverage
Interest Cover X Lock Lock Lock Lock 52.5 65.9 54.5 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -0.7 -0.4 -0.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -20.2 -14.7 -2.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.4 2.3 2.4 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.8 1.7 1.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 40.8 35.4 19.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 62.7 61.6 39.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.6 4.7 4.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.7 1.6 1.4 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 2.5 2.8 2.9 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 13.8 13.4 12.7 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.8 0.8 0.8 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.8 0.8 0.8 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 20.3 21.5 22.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 15.4 17.7 18.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 24.2 26.4 25.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 11.7 13.0 13.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.5 1.5 1.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 17.2 19.4 19.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 27.8 24.7 27.6 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 4.8 4.8 5.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 217.5 228.3 264.3 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 79.1 77.5 85.2 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 296.7 305.8 349.5 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 173.4 163.0 151.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 123.3 142.8 197.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

18-Sep-25

DIV Yield

1.4%

Franking Level

85%

DPSg

4.90%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

2.31%

Value ($M)

480

Prior Change

N/A

7 Day Change

0.20%

1 Month Change

0.40%

3 Month Change

1.60%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

COH Shortsell

Frequently Asked Questions

The current share price of Cochlear Limited (COH:ASX) is AU$301.01.
The 52-week high share price for Cochlear Limited (COH:ASX) is AU$323.00.
The 52-week low share price for Cochlear Limited (COH:ASX)? is AU$246.14.
The current TTM dividend payout for Cochlear Limited (COH:ASX) is 1.40.
The last dividend payment of Cochlear Limited (COH:ASX) is AU$2.15.
Cochlear Limited (COH:ASX) has a franking level of 85.0%.
Cochlear Limited (COH:ASX) is classified in the Healthcare.
The current P/E ratio for Cochlear Limited (COH:ASX) is 50.50.
The current share price of Cochlear Limited (COH:ASX) is AU$301.01.
The 52-week high share price for Cochlear Limited (COH:ASX) is AU$323.00.
The 52-week low share price for Cochlear Limited (COH:ASX)? is AU$246.14.
The current TTM dividend payout for Cochlear Limited (COH:ASX) is 1.40.
The last dividend payment of Cochlear Limited (COH:ASX) is AU$2.15.
Cochlear Limited (COH:ASX) has a franking level of 85.0%.
Cochlear Limited (COH:ASX) is classified in the Healthcare.
The current P/E ratio for Cochlear Limited (COH:ASX) is 50.50.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.